197 related articles for article (PubMed ID: 26187732)
1. Effect of deworming on Th2 immune response during HIV-helminths co-infection.
Mulu A; Anagaw B; Gelaw A; Ota F; Kassu A; Yifru S
J Transl Med; 2015 Jul; 13():236. PubMed ID: 26187732
[TBL] [Abstract][Full Text] [Related]
2. Deworming and the immune status of HIV positive pre-antiretroviral therapy individuals in Arba Minch, Chencha and Gidole hospitals, Southern Ethiopia.
Abossie A; Petros B
BMC Res Notes; 2015 Sep; 8():483. PubMed ID: 26415705
[TBL] [Abstract][Full Text] [Related]
3. Deworming of intestinal helminths reduces HIV-1 subtype C viremia in chronically co-infected individuals.
Mulu A; Maier M; Liebert UG
Int J Infect Dis; 2013 Oct; 17(10):e897-901. PubMed ID: 23688549
[TBL] [Abstract][Full Text] [Related]
4. Serum IgE levels of tuberculosis patients in a tropical setup with high prevalence of HIV and intestinal parasitoses.
Kassu A; Mohammad A; Fujimaki Y; Moges F; Elias D; Mekonnen F; Mengistu G; Yamato M; Wondmikun Y; Ota F
Clin Exp Immunol; 2004 Oct; 138(1):122-7. PubMed ID: 15373914
[TBL] [Abstract][Full Text] [Related]
5. The magnitude and risk factors of intestinal parasitic infection in relation to Human Immunodeficiency Virus infection and immune status, at ALERT Hospital, Addis Ababa, Ethiopia.
Taye B; Desta K; Ejigu S; Dori GU
Parasitol Int; 2014 Jun; 63(3):550-6. PubMed ID: 24603288
[TBL] [Abstract][Full Text] [Related]
6. Helminths and malaria co-infections are associated with elevated serum IgE.
Mulu A; Kassu A; Legesse M; Erko B; Nigussie D; Shimelis T; Belyhun Y; Moges B; Ota F; Elias D
Parasit Vectors; 2014 May; 7():240. PubMed ID: 24886689
[TBL] [Abstract][Full Text] [Related]
7. The effect of three-monthly albendazole treatment on Th2 responses: Differential effects on IgE and IL-5.
de Ruiter K; Tahapary DL; Wammes LJ; Wiria AE; Hamid F; van Lieshout L; Smit JWA; Houwing-Duistermaat JJ; Sartono E; Supali T; Yazdanbakhsh M
Parasite Immunol; 2017 Jun; 39(6):. PubMed ID: 28370210
[TBL] [Abstract][Full Text] [Related]
8. Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
Walson JL; Otieno PA; Mbuchi M; Richardson BA; Lohman-Payne B; Macharia SW; Overbaugh J; Berkley J; Sanders EJ; Chung MH; John-Stewart GC
AIDS; 2008 Aug; 22(13):1601-9. PubMed ID: 18670219
[TBL] [Abstract][Full Text] [Related]
9. Effects of albendazole on the clinical outcome and immunological responses in helminth co-infected tuberculosis patients: a double blind randomised clinical trial.
Abate E; Elias D; Getachew A; Alemu S; Diro E; Britton S; Aseffa A; Stendahl O; Schön T
Int J Parasitol; 2015 Feb; 45(2-3):133-40. PubMed ID: 25486494
[TBL] [Abstract][Full Text] [Related]
10. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi-site, randomised trial.
Walson J; Singa B; Sangaré L; Naulikha J; Piper B; Richardson B; Otieno PA; Mbogo LW; Berkley JA; John-Stewart G
Lancet Infect Dis; 2012 Dec; 12(12):925-32. PubMed ID: 22971323
[TBL] [Abstract][Full Text] [Related]
11. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults.
Elliott AM; Mawa PA; Joseph S; Namujju PB; Kizza M; Nakiyingi JS; Watera C; Dunne DW; Whitworth JA
Trans R Soc Trop Med Hyg; 2003; 97(1):103-8. PubMed ID: 12886815
[TBL] [Abstract][Full Text] [Related]
12. Community deworming alleviates geohelminth-induced immune hyporesponsiveness.
Wammes LJ; Hamid F; Wiria AE; May L; Kaisar MM; Prasetyani-Gieseler MA; Djuardi Y; Wibowo H; Kruize YC; Verweij JJ; de Jong SE; Tsonaka R; Houwing-Duistermaat JJ; Sartono E; Luty AJ; Supali T; Yazdanbakhsh M
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12526-12531. PubMed ID: 27791067
[TBL] [Abstract][Full Text] [Related]
13. Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy.
Lankowski AJ; Tsai AC; Kanyesigye M; Bwana M; Haberer JE; Wenger M; Martin JN; Bangsberg DR; Hunt PW; Siedner MJ
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3036. PubMed ID: 25101890
[TBL] [Abstract][Full Text] [Related]
14. Deworming helminth co-infected individuals for delaying HIV disease progression.
Walson JL; Herrin BR; John-Stewart G
Cochrane Database Syst Rev; 2009 Jul; (3):CD006419. PubMed ID: 19588389
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
16. The impact of asymptomatic helminth co-infection in patients with newly diagnosed tuberculosis in north-west Ethiopia.
Abate E; Belayneh M; Gelaw A; Idh J; Getachew A; Alemu S; Diro E; Fikre N; Britton S; Elias D; Aseffa A; Stendahl O; Schön T
PLoS One; 2012; 7(8):e42901. PubMed ID: 22952620
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and correlates of helminth co-infection in Kenyan HIV-1 infected adults.
Walson JL; Stewart BT; Sangaré L; Mbogo LW; Otieno PA; Piper BK; Richardson BA; John-Stewart G
PLoS Negl Trop Dis; 2010 Mar; 4(3):e644. PubMed ID: 20361031
[TBL] [Abstract][Full Text] [Related]
18. The influence of different helminth infection phenotypes on immune responses against HIV in co-infected adults in South Africa.
Mkhize-Kwitshana ZL; Taylor M; Jooste P; Mabaso ML; Walzl G
BMC Infect Dis; 2011 Oct; 11():273. PubMed ID: 21999928
[TBL] [Abstract][Full Text] [Related]
19. Effect of deworming on disease progression markers in HIV-1-infected pregnant women on antiretroviral therapy: a longitudinal observational study from Rwanda.
Ivan E; Crowther NJ; Mutimura E; Rucogoza A; Janssen S; Njunwa KK; Grobusch MP
Clin Infect Dis; 2015 Jan; 60(1):135-42. PubMed ID: 25210019
[TBL] [Abstract][Full Text] [Related]
20. Recall of intestinal helminthiasis by HIV-infected South Africans and avoidance of possible misinterpretation of egg excretion in worm/HIV co-infection analyses.
Adams VJ; Markus MB; Kwitshana ZL; Dhansay MA; van der Merwe L; Walzl G; Fincham JE
BMC Infect Dis; 2006 May; 6():88. PubMed ID: 16725057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
